NALIRIFOX trials for Pancreatic cancer

All NALIRIFOX trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying NALIRIFOX for Pancreatic cancer

• Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
  NCT06483555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
  NCT07030283 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
  NCT06736717 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study NALIRIFOX for Pancreatic cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.